Eton Pharmaceuticals (ETON) Invested Capital (2017 - 2025)

Eton Pharmaceuticals has disclosed Invested Capital across 9 years of filings, most recently posting $34.9 million for Q4 2025.

• Invested Capital for Q4 2025 came in at $34.9 million, down 35.58% year-over-year; the trailing twelve-month figure through Dec 2025 was $34.9 million (down 35.58% YoY), and the FY2025 annual result was $34.9 million, down 35.58% from the prior year.
• Invested Capital came in at $34.9 million for Q4 2025 at Eton Pharmaceuticals, up from $25.9 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $54.4 million in Q1 2025 to a low of $15.5 million in Q4 2023.
• The 5-year median for Invested Capital is $21.1 million (2021), against an average of $25.1 million.
• Across the five-year window, Invested Capital soared 250.45% in 2024 and tumbled 35.58% in 2025, its largest moves.
• Eton Pharmaceuticals' Invested Capital stood at $22.9 million in 2021, then declined by 19.35% to $18.5 million in 2022, then fell by 16.17% to $15.5 million in 2023, then jumped by 250.45% to $54.2 million in 2024, then sank by 35.58% to $34.9 million in 2025.
• The last three Invested Capital figures came in at $34.9 million (Q4 2025), $25.9 million (Q3 2025), and $26.7 million (Q2 2025), per Business Quant data.